Jason Ryan - Net Worth and Insider Trading

Jason Ryan Net Worth

The estimated net worth of Jason Ryan is at least $8 Million dollars as of 2024-04-27. Jason Ryan is the CFO of Foundation Medicine Inc and owns about 49,170 shares of Foundation Medicine Inc (FMI) stock worth over $7 Million. Jason Ryan is also the Executive Chairman of GeneDx Holdings Corp and owns about 120,576 shares of GeneDx Holdings Corp (WGS) stock worth over $1 Million. Details can be seen in Jason Ryan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Ryan has not made any transactions after 2023-11-17 and currently still holds the listed stock(s).

Transaction Summary of Jason Ryan

To

Jason Ryan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Ryan owns 5 companies in total, including Magenta Therapeutics Inc (MGTA) , Foundation Medicine Inc (FMI) , and GeneDx Holdings Corp (WGS) among others .

Click here to see the complete history of Jason Ryan’s form 4 insider trades.

Insider Ownership Summary of Jason Ryan

Ticker Comapny Transaction Date Type of Owner
MGTA Magenta Therapeutics Inc 2019-01-01 See Remarks
FMI Foundation Medicine Inc 2018-07-31 Chief Financial Officer
WGS GeneDx Holdings Corp 2023-11-17 director
OMIC Singular Genomics Systems Inc 2021-05-26 director
SLGC SomaLogic Inc 2023-06-08 director

Jason Ryan Latest Holdings Summary

Jason Ryan currently owns a total of 2 stocks. Among these stocks, Jason Ryan owns 49,170 shares of Foundation Medicine Inc (FMI) as of July 2, 2018, with a value of $7 Million and a weighting of 83.45%. Jason Ryan also owns 120,576 shares of GeneDx Holdings Corp (WGS) as of November 17, 2023, with a value of $1 Million and a weighting of 16.55%.

Latest Holdings of Jason Ryan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FMI Foundation Medicine Inc 2018-07-02 49,170 137.00 6,736,290
WGS GeneDx Holdings Corp 2023-11-17 120,576 11.08 1,335,982

Holding Weightings of Jason Ryan


Jason Ryan Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Ryan has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 3,403 shares on July 2, 2018, which brought Jason Ryan around $465,054.

According to the SEC Form 4 filings, Jason Ryan has made a total of 4 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in GeneDx Holdings Corp is the acquisition of 114,742 shares on November 17, 2023, which cost Jason Ryan around $161,786.

Insider Trading History of Jason Ryan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Ryan Trading Performance

GuruFocus tracks the stock performance after each of Jason Ryan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Ryan is 215.63%. GuruFocus also compares Jason Ryan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Ryan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jason Ryan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jason Ryan

Average Return

No transaction record over 1 year.

Outperforming Transactions

No transaction record over 1 year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 51.88 215.63
Relative Return to S&P 500(%) 47.33 204.74

Jason Ryan Ownership Network

Ownership Network List of Jason Ryan

No Data

Ownership Network Relation of Jason Ryan


Jason Ryan Owned Company Details

What does Magenta Therapeutics Inc do?

Who are the key executives at Magenta Therapeutics Inc?

Jason Ryan is the See Remarks of Magenta Therapeutics Inc. Other key executives at Magenta Therapeutics Inc include director & 10 percent owner Peter Evan Harwin , director & 10 percent owner Tomas Kiselak , and director & 10 percent owner Fairmount Funds Management Llc .

Magenta Therapeutics Inc (MGTA) Insider Trades Summary

Over the past 18 months, Jason Ryan made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Magenta Therapeutics Inc Insider Transactions

No Available Data

Jason Ryan Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Ryan. You might contact Jason Ryan via mailing address: C/o Foundation Medicine, Inc., One Kendall Square, Suite B3501, Cambridge Ma 02139.

Discussions on Jason Ryan

No discussions yet.